News | November 03, 2021
WHO issues emergency use listing for Covaxin
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
Filing marks first protein-based vaccine submitted to MHRA for authorization
This unique record was made possible by collating hard copies of the books in a structured manner
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care
It recommends using the vaccine to prevent the spread of the disease
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
A total of 8308 stores are open across India and medicines are priced at affordable rates
It is a recombinant nanoparticle protein-based vaccine
Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses
Subscribe To Our Newsletter & Stay Updated
